CD47 and melanoma: While we observed small increases in M14 and TLM1 melanoma cell phagocytosis in response to CD47 blockade, the overall percent phagocytosis of these cells (3.7 ± 1.0% and 12.4 ± 2.0%, respectively) remained low as compared to lymphoma cells (Fig. 3b–d).